von Dagmar jürgens | Sep 2, 2020
Philipp Bürling appointed CEO of Priavoid Philipp Bürling appointed CEO of Priavoid We are pleased to inform you that Philipp Bürling has been appointed CEO of Priavoid GmbH as of September 1st, 2020. Philipp holds Master degrees in business informatics and business...
von Gunther Kauselmann | Mrz 6, 2020
Office establishmentDüsseldorf Priavoid established an office at the Life Science Center, Düsseldorf, Germany. News & Events: Office establishment6. März 2020 09th BIO.NRW Business Angel Congress3. März 2020 BIO-EUROPE SPRING 20203. März 2020 AD/PD 202014. Februar...
von Gunther Kauselmann | Mrz 3, 2020
BIO-EUROPE SPRING 2020March 23rd – 25th, 2020 Learn more Priavoid participated at the BIO-Europe Spring. News & Events: Office establishment6. März 2020 BIO-EUROPE SPRING 20203. März 2020 Seed Investment6. Mai 2019 CEOs of Priavoid3. Mai 2019 Prof....
von Dagmar jürgens | Mai 6, 2019
Seed Investment March 28th, 2019 Priavoid obtained seed investment. News & Events: AAIC 2019 Keystone Symposium Neuro4D Conference Seed Investment CEOs of Priavoid AD/PD 2019 – Lisbon BioRiver Boost! 2018 The Nobel Prize Prof. Willbold´s interview with...
von Gunther Kauselmann | Jan 23, 2018
Prof. Willbold´s interview with PharmaVentures November 14th, 2017 Learn more Prof. Dieter Willbold talks with Summer Park of PharmaVentures at Biotech and Money Investival, London in 2017. News & Events: AAIC 2019 Keystone Symposium Neuro4D Conference Seed...
Neueste Kommentare